Siren LLC’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.4M Buy
11,014,737
+4,500,000
+69% +$10.4M 1.32% 23
2025
Q1
$9.06M Sell
6,514,737
-87,738
-1% -$122K 0.51% 41
2024
Q4
$11.4M Buy
6,602,475
+1,722,600
+35% +$2.98M 0.5% 44
2024
Q3
$9.81M Buy
+4,879,875
New +$9.81M 0.49% 45